SynthesisPloS one2020

Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis.

Jiani Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.